These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6760793

  • 21. Variation of in vitro lymphocyte responses to M. leprae antigen in borderline tuberculoid leprosy patients.
    Bjune G.
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):30-40. PubMed ID: 6154019
    [No Abstract] [Full Text] [Related]

  • 22. [Serodiagnostic monitoring of leprosy].
    Diachina MN.
    Probl Tuberk Bolezn Legk; 2003 Mar; (11):32-9. PubMed ID: 14689796
    [No Abstract] [Full Text] [Related]

  • 23. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
    Abe M, Minagawa F, Yoshino Y, Okamura K.
    Int J Lepr Other Mycobact Dis; 1972 Mar; 40(2):107-17. PubMed ID: 4119113
    [No Abstract] [Full Text] [Related]

  • 24. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM, Muthukkaruppan V.
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [Abstract] [Full Text] [Related]

  • 25. Antibody response in rabbits to immunization with Mycobacterium leprae.
    Harboe M, Closs O, Bjorvatn B, Kronvall G, Axelsen NH.
    Infect Immun; 1977 Dec; 18(3):792-805. PubMed ID: 338491
    [Abstract] [Full Text] [Related]

  • 26. Occurrence of antigen BCG 60 in leprosy derived corynebacteria and other coryneforms.
    Papa FP, Rauzier JY, David HL.
    Acta Leprol; 1984 Dec; 2(2-4):351-8. PubMed ID: 6398594
    [Abstract] [Full Text] [Related]

  • 27. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 28. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu, Kalianina OV.
    Probl Tuberk; 1995 Dec; (2):47-8. PubMed ID: 7777465
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Godal T, Myrvang B, Samuel DR, Ross WF, Lofgren M.
    Acta Pathol Microbiol Scand Suppl; 1973 Dec; 236(0):45-53. PubMed ID: 4602874
    [No Abstract] [Full Text] [Related]

  • 30. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH, Rees RH, Liew FY.
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [Abstract] [Full Text] [Related]

  • 31. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM, Sampaio EP, de Moraes MO, Albuquerque EC, Castro AP, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [Abstract] [Full Text] [Related]

  • 32. Immunochemical characteristics and differentiation of Nocardiae.
    Estrada-Parra S.
    Rev Latinoam Microbiol; 1973 Jun; 15(2):87-93. PubMed ID: 4202913
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):48-55. PubMed ID: 7730719
    [Abstract] [Full Text] [Related]

  • 34. Antibodies against BCG antigen 60 in mycobacterial infection.
    Harboe M, Closs O, Bjorvatn B, Bjune G.
    Br Med J; 1977 Aug 13; 2(6084):430-3. PubMed ID: 407965
    [Abstract] [Full Text] [Related]

  • 35. Detection of antigen in Nocardia caviae cross-reacting with mycobacterial antigen No. 21 in M. leprae using a lepromatous leprosy serum pool as antibody reagent.
    Bjorvatn B, Kronvall G.
    Int J Lepr Other Mycobact Dis; 1980 Sep 13; 48(3):260-6. PubMed ID: 7002810
    [Abstract] [Full Text] [Related]

  • 36. Antimycobacterial antibodies in Dasypus novemcinctus infected with Mycobacterium leprae and their correlation with the serum levels of lactate dehydrogenase.
    Rojas-Espinosa O, Mendez P, Oltra A, Arce P.
    Lepr Rev; 1986 Dec 13; 57(4):317-27. PubMed ID: 3540494
    [No Abstract] [Full Text] [Related]

  • 37. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.
    Convit J, Pinardi ME, Rodríguez Ochoa G, Ulrich M, Avila JL, Goihman M.
    Clin Exp Immunol; 1974 Jun 13; 17(2):261-5. PubMed ID: 4619359
    [Abstract] [Full Text] [Related]

  • 38. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
    Lagrange PH.
    Trop Med Parasitol; 1990 Sep 13; 41(3):304-6. PubMed ID: 2255850
    [No Abstract] [Full Text] [Related]

  • 39. Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.
    Roche PW, Neupane KD, Britton WJ.
    Clin Exp Immunol; 1992 Jul 13; 89(1):110-4. PubMed ID: 1628419
    [Abstract] [Full Text] [Related]

  • 40. Effect of specific vaccine on cell-mediated immunity of armadillos against M. leprae.
    Kirchheimer WF, Sanchez RM, Shannon EJ.
    Int J Lepr Other Mycobact Dis; 1978 Jul 13; 46(3-4):353-7. PubMed ID: 365788
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.